Cronos Group Revenue and Competitors

Claim your profile

Toronto, ON CAN



Total Funding



Estimated Revenue & Valuation

  • Cronos Group's estimated annual revenue is currently $7M per year.(i)
  • Cronos Group received $65.0M in venture funding in January 2019.
  • Cronos Group's estimated revenue per employee is $13,436
  • Cronos Group's total funding is $1.8B.

Employee Data

  • Cronos Group has 521 Employees.(i)
  • Cronos Group grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents. The Company operates two wholly-owned Canadian Licensed Producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc. (Ontario), which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd. (British Columbia), which is based in the Okanagan Valley. The Company has multiple international production and distribution platforms: Cronos Israel and Cronos Australia. Through an exclusive distribution agreement, Cronos also has access to over 12,000 pharmacies in Germany as the Company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Cronos Group News

2022-04-19 - Cronos Group Inc. stock outperforms market despite losses on the day

This was the stock's third consecutive day of losses. Cronos Group Inc. closed $6.36 short of its 52-week high ($9.42), which the company...

2022-04-17 - Cronos Group Inc. stock falls Thursday, underperforms market

Cronos Group Inc. closed $6.30 short of its 52-week high ($9.42), which the company achieved on June 9th. The stock underperformed when compared...

2022-04-17 - Is Cronos Group Inc (CRON) a Poor Choice in the Healthcare Sector?

Cronos Group Inc's score of 22 means that it ranks higher than 22% of stocks in the sector. In addition, its overall score of 26 ranks it higher...

2021-10-20 - Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy

Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plant The SPINACH FEELZ™ platform’s latest product innovation, the Chill Bliss gummy, is a first-of-its kind CBG ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Cronos Group Funding

DateAmountRoundLead InvestorsReference
2018-12-10$1800.0MUndisclosedAltria GroupArticle
2019-01-24$65.0MUndisclosedCanadian Imperial Bank of CommerceArticle